SCHEMBL8088060

SCHEMBL8088060

Clc1ncnc2c1c(-c1ccccc1)c(-c1ccccc1)n2Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.59
KMT2A Q03164 9/20 0.59
NR2F2 P24468 1/20 0.59
LMNA P02545 9/20 0.54
NPSR1 Q6W5P4 7/20 0.54
HTT P42858 7/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
KDM4E B2RXH2 5/20 0.54
GAA P10253 3/20 0.54
ALDH1A1 P00352 7/20 0.52
NPC1 O15118 2/20 0.52
PTBP1 P26599 1/20 0.52
ADRA2C P18825 1/20 0.50
ADRA1D P25100 1/20 0.50
HRH1 P35367 1/20 0.50
SLC6A3 Q01959 1/20 0.50
TMEM97 Q5BJF2 1/20 0.50
MAPT P10636 4/20 0.47
ATM Q13315 1/20 0.47
HPGD P15428 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3053808 0.89 MEN1 (0.52) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL3053593 0.89 MEN1 (0.52) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL8089684 0.85 MEN1 (0.56) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL4854445 0.83 MEN1 (0.43) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL14193669 0.78 SRC (0.50) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL3056032 0.76 HTT (0.53) MEN1KMT2ALMNANPSR1HTT
SCHEMBL3053024 0.76 HTT (0.53) MEN1KMT2ALMNANPSR1HTT
SCHEMBL16202886 0.75 NPSR1 (0.80) MEN1KMT2ALMNANPSR1HTT
SCHEMBL2464129 0.74 MEN1 (1.00) MEN1KMT2ANR2F2LMNANPSR1
SCHEMBL27888661 0.73 ALDH1A1 (0.49) MEN1KMT2ALMNANPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096749-A ANTITUMOR, EPIDERMAL GROWTH FACTOR NOVARTIS CORPORATION (US) 2000-08-01 US disclosed
EP-0682027-B1 Pyrrolopyrimidine derivatives with antiproliferative action CIBA GEIGY AG (CH) 1997-10-15 EP disclosed
EP-0682027-A1 Pyrrolopyrimidine derivatives with antiproliferative action CIBA-GEIGY AG (CH) 1995-11-15 EP disclosed